NCT03061435View on ClinicalTrials.gov

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 1, 2025

Study Completion Date

January 1, 2026

Conditions
Vulvar CancerCervical CancerVulvar DysplasiaCervical DysplasiaAnal CancerAnal DysplasiaHPV-Related Anal Squamous Cell Carcinoma
Interventions
PROCEDURE

Screening anal Pap smear - No high-resolution anoscopy

75% of patients with negative cytology on their anal Pap smear will not receive high-resolution anoscopy

PROCEDURE

Screening anal Pap smear - High-resolution anoscopy

25% of patients with negative cytology on their anal Pap smear will receive high-resolution anoscopy. All patients with positive (abnormal) cytology on their anal Pap smear will receive high-resolution anoscopy.

Trial Locations (1)

M4N 3M5

RECRUITING

Odette Cancer Centre, Toronto

All Listed Sponsors
lead

Dr. Danielle Vicus

OTHER